Coinciding with this year’s International Nurses Day, this week’s Federal Budget has had some significant outcomes for the primary health care, nursing workforce.
The Federal Budget delivered on 9th May 2023, APNA believes will strengthen Australia’s primary health care (PHC) system by addressing growing nursing shortages, seeing more nurses hired where they are needed, and better utilising the largest workforce in PHC of nearly 100,000 nurses to their full potential to reduce the pressure on the health system.
The Federal Budget could significantly boost job prospects and career progression in primary healthcare, as well as strengthen the current PHC nursing workforce by funding:
- An 18-month national Scope of Practice review
- 6,000 additional clinical placements in primary healthcare nursing ($4.2 million over four years)
- 1,850 graduate scholarships to train more Nurse Practitioners ($50.2 million over four years)
- $1 million towards incentives to get 500 nurses back into the workforce
Australian Health Journal met with APNA President Karen Booth and CEO Ken Griffin at their Money in May 2023 event in Sydney.
Money in May is an APNA member-only initiative and is a month of education so that nurses know more about money and how to navigate the financial side of being a nurse. The campaign has three key themes: do more, save more and earn more.
Timed to coincide with the end of the financial year, APNA has focused on financial literacy. Nurses who understand the opportunities and challenges of finance and funding mechanisms and keep abreast of changes can be an even greater asset for their patients and the business they work for. For their personal lives, they make better financial decisions, earn more and retire with more super.
The outcomes are for each Primary healthcare nurse in a time to influence and pitch for what they want — be that money to fund a nurse-led clinic, a financial allocation for CPD or negotiate pay.
Relating that back to the funding announcements in the Federal Budget, there is potential to significantly boost job prospects and career progression in primary healthcare, as well as strengthen the current PHC nursing workforce.
-
Belonging in a medical device company
Edith de Boer is the HR Director for Zimmer Biomet in Australia and New Zealand. Her career originally was in telecommunications and consulting in Europe. After leaving The Netherlands, Edith worked into the Australian medical research industry, before moving into a human resources role at Zimmer Biomet. Edith spoke to Australian Health Journal about her role and the organisation.
-
ICTD: Why negative results in clinical trials matter
To mark International Clinical Trials Day 2026, Australian Health Journal commences a 4 part special series leaving up to 20th May. Through conversations with leading researchers, clinicians and trial organisations, the series highlights achievements in the year that was for clinical trials.
Negative results in a clinical trial can be extremely valuable — both scientifically and ethically. A “negative result” usually means the treatment being tested did not work better than the standard treatment, placebo, or expected outcome.Negative results in a clinical trial can be extremely valuable — both scientifically and ethically. A “negative result” usually means the treatment being tested did not work better than the standard treatment, placebo, or expected outcome.
-
Significant funding announced for NSW biomedical researchers
The Snow Medical Research Foundation (Snow Medical) has announced a new $24 million investment in three outstanding Australian biomedical researchers through its prestigious Snow Fellowships.
These Fellows will tackle major global health challenges spanning autoimmune disease, neurological disorders, and genetic disease. Their work addresses conditions that disproportionately affect vulnerable and underserved populations, including First Nations communities, while advancing precision medicine and translational care. Collectively, their research aims to deliver safer vaccines, better diagnostics, and more equitable genomic and neurological healthcare.
